• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1500200-38
Device Problem Difficult to Remove (1528)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/14/2022
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat the heavily calcified, heavily tortuous, 70% stenosed left anterior descending (lad) coronary artery.The turntrac guide wire was being removed after stenting in the posterior descending and right coronary arteries (rca) and the distal portion separated and remained in the rca.There was resistance with the stent noted during removal of the turntrac guide wire after stent implant.The coils were lost and could not be retrieved.After a while the flow of the rca became slow and the patient became unstable due to a drop in blood pressure.Cardiopulmonary resuscitation (cpr) was performed and the patient was transferred to a different hospital.The patient expired 5-6 days later.The rca was stented with a 3.0x38 mm xience sierra and the turntrac guide wire was used as a second wire.The xience sierra stent was implanted without issue, and there were no adverse patient effects due to the xience sierra stent.No additional information was provided.
 
Manufacturer Narrative
The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The additional 014 ht turntrac device referenced is filed under separate medwatch report number.
 
Event Description
Subsequent to the initially filed report, it was reported that the rca and posterior descending arteries (pda) had diffuse disease with 20% calcification, 20% tortuosity.The rca was stented with a xience stent and the turntrac guide wire was used as a second wire.Additionally, the stent was a 3.0x38 mm xience sierra and it was implanted without issue, and there were no adverse patient effects due to the xience sierra stent.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported difficulty to remove (guidewire); however, factors that may contribute to difficulty removing the guide wire include, but are not limited to, patient¿s disease state, patient¿s anatomical morphology, interaction with an accessory device, and/or damage to the guide wire.In this case, it is possible that an interaction between the guide wire and deployed stent may have contributed to the reported difficult to remove; however, this cannot be confirmed.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16009311
MDR Text Key306886415
Report Number2024168-2022-12832
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeHK
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/07/2023
Device Catalogue Number1500200-38
Device Lot Number0120341
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/08/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
TURNTRAC GUIDE WIRE
-
-